Adrian Adams, CEO and President at AUXILIUM PHARMACEUTICALS INC (AUXL), sold 40,000 shares at $33.97 ($1.4M) on 2014-12-05, disclosed to the SEC on 2014-12-08.
Open-market sale of $1.4M AUXL by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKBA | BUY | 2019-11-21 | $171K | — | Filing → |
| ARLZ | BUY | 2017-03-17 | $1.2M | — | Filing → |
| POZN | BUY | 2015-11-12 | $6.6M | — | Filing → |